O=C(/C=C/c1cccc([N+](=O)[O-])c1)N1CC[C@@]2(O)CCCC[C@H]2C1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?